Vasectomy Market is Segmented By Type (Conventional Vasectomy, No-Scalpel Vasectomy, Minimally Invasive Vasectomy), By Drugs (Anesthetics, Antibiotics, Painkillers), By Patient (Human, Animal), By End user (Hospitals, Ambulatory Surgical Center, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Market Overview
The global vasectomy market size was valued US$ XX million in 2023 and is estimated to reach US$ XX million by 2031, growing at a CAGR of XX % during the forecast period (2024-2031).
Vasectomy is a surgical technique for male sterilization or permanent contraception performed as elective surgery. The male vasa deferentia is cut and knotted or sealed during the surgery to prevent sperm from entering the urethra and fertilizing a female through sexual intercourse. It is a simple surgery that takes less time and requires no hospitalization. Vasectomy is performed in relatively low numbers as compared to tubectomy.
Source: DataM Intelligence Analysis (2021)
Market Dynamics
Innovative technologies for the Vasectomy procedure are expected to drive market growth.
Focused ultrasound is a non-invasive, early-stage treatment tool that has the potential to improve the quality of life and lower the cost of care for vasectomy patients. This cutting-edge technology concentrates ultrasonic energy beams on specific locations within the body while avoiding damage to healthy tissue in the surrounding area. Moreover, focused ultrasound produces precise ablation (heat destruction of tissue) where the beams converge, allowing vasectomy to be performed with minimum (and possibly no) bodily invasion. It can reach the desired target without damaging surrounding tissue and is repeatable, if necessary, and also does not carry added concerns associated with acid agents. Thus, the market is expected to drive in the forecast period from the above statements.
Restraint:
The market growth is expected to be hampered by side effects associated with Vasectomy Surgical Procedures. For instance, Fever and chills, redness, swelling, extreme pain or bleeding or discharge at the incision site, difficulty urinating, and pain that you can't control with drugs are all signs of infection.
Industry Analysis
Porter’s Five Forces:
Source: DataM Intelligence Analysis (2021)
Supply Chain Analysis:
COVID-19 Impact Analysis
The COVID-19 pandemic has moderately impacted healthcare systems and the market. The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)-caused (by COVID-19) has become a global epidemic with numerous health consequences. Because men are more susceptible to COVID-19 than women, there is growing worried about the impact of SARS-CoV-2 infection on male fertility and the possibility of seminal contamination and transmission. Many reproductive clinics and pathology laboratories were temporarily shut down due to the epidemic, while many of them stayed open. Moreover, SARS-CoV-2 can contaminate the semen of COVID-19 patients and those of recovered patients, according to a few instances. The virus's entrance into the testis may be due to inflammatory responses disrupting the testis' anatomical barriers. The virus's persistence in the semen may be aided by testicular immunological privilege. Because SARS-CoV-2 is an encased RNA virus, it is theoretically plausible that the virus may survive cryopreservation with liquid nitrogen in the semen samples.
Additionally, the pandemic interrupts the supply chain. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of the economic activities.
Market Segment Analysis
No-Scalpel Vasectomy segment is expected to hold the largest market share in vasectomy market
The No-scalpel vasectomy segment is expected to dominate in 2021. The segment's growth is beneficial because it is an extremely safe and effective procedure, with more than 99% success rates. Similarly, as with traditional procedures, these vasectomies eliminate the potential for human error that comes with temporary alternatives, such as a broken condom or a forgotten birth control pill. Moreover, it requires no sutures to close up incisions. Therefore it has increased the demand for the procedure. Thus, the market segment is expected to hold the largest market share in the forecast period from the above statements
.
Source: DataM Intelligence Analysis (2021)
Market Geographical Share
North America region holds the largest market share in the global vasectomy market
In 2021, North America accounted for the highest revenue share. The increasing prevalence of vasectomy, rising geriatric population, well-established infrastructure, advancement in diagnosis and increasing clinical trials in the region are some factors the market is expected to boost in the forecast period. For instance, according to the American Urological Association, conception occurs in about one out of every 2,000 couples where one partner has a penis and the other has had a vasectomy. In contrast, about 50 million men have had a vasectomy — approximately 5% of all reproductive-age married men. More than 500,000 men elect to have vasectomies every year in the U.S. Therefore, has increased the demand for surgical procedures. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.
Source: DataM Intelligence Analysis (2021)
Market Competitive Landscape
Major key players in the vasectomy market are Bristol-Myers Squibb Company, Teva Pharmaceuticals USA, Inc., Upsher-Smith Laboratories, LLC, Pfizer Inc., Smithfield BioScience, Opocrin S.p.A., Bioiberica S.A.U., GlaxoSmithKline plc., Johnson & Johnson Consumer Inc., Fresenius SE & Co. KGaA.
Pfizer Inc.:
Overview:
Pfizer Inc. is an American multinational pharmaceutical company that offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. It has a portfolio of over 150 products across 15 therapeutic areas. The company develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, endocrinology, and neurology.
Product Portfolio:
Heparin sodium Injection: Heparin Sodium Injection is an anticoagulant used to prevent blood clots from forming in people who have certain medical conditions or undergo certain medical procedures that increase the chance of clots forming.
Why Purchase the Report?
- Visualize the composition of the vasectomy market segmentation by type, drugs, patient, end user, distribution channel and region highlighting the key commercial assets and players.
- Identify commercial opportunities in vasectomy market by analyzing trends and co-development deals.
- Excel data sheet with thousands of data points of vasectomy market- level 4/5 segmentation.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in excel for the key product of all major market players
The global vasectomy market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.
Target Audience
- Service Providers/ Buyers
- Industry Investors/Investment Bankers
- Education & Research Institutes
- Research Professionals
- Emerging Companies
- Manufacturers
